Literature DB >> 27350384

A model for patient-direct screening and referral for familial cancer risk.

Kristin B Niendorf1,2, Melissa A Geller3, Rachel Isaksson Vogel4, Timothy R Church5, Anna Leininger6, Angela Bakke7, Robert D Madoff8.   

Abstract

Patients at increased familial risk of cancer are sub-optimally identified and referred for genetic counseling. We describe a systematic model for information collection, screening and referral for hereditary cancer risk. Individuals from three different clinical and research populations were screened for hereditary cancer risk using a two-tier process: a 7-item screener followed by review of family history by a genetic counselor and application of published criteria. A total of 869 subjects participated in the study; 769 in this high risk population had increased familial cancer risk based on the screening questionnaire. Of these eligible participants, 500 (65.0 %) provided family histories and 332 (66.4 %) of these were found to be at high risk of a hereditary cancer syndrome, 102 (20.4 %) at moderate familial cancer risk, and 66 (13.2 %) at average risk. Three months following receipt of the risk result letter, nearly all respondents found the process at least somewhat helpful (98.4 %). All participants identified as high-risk were mailed a letter recommending genetic counseling and were provided appointment tools. After 1 year, only 13 (7.3 %) of 179 high risk respondents reported pursuit of recommended genetic counseling. Participants were willing to provide family history information for the purposes of risk assessment; however, few patients pursued recommended genetic services. This suggests that cancer family history registries are feasible and viable but that further research is needed to increase the uptake of genetic counseling.

Entities:  

Keywords:  Cancer; Familial; Family history; Genetic; Genetic counseling; Hereditary; Uptake

Mesh:

Year:  2016        PMID: 27350384      PMCID: PMC5189683          DOI: 10.1007/s10689-016-9912-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  38 in total

1.  NCCN increases the emphasis on genetic/familial high-risk assessment in colorectal cancer.

Authors:  Heather Hampel
Journal:  J Natl Compr Canc Netw       Date:  2014-05       Impact factor: 11.908

2.  Use of a patient-entered family health history tool with decision support in primary care: impact of identification of increased risk patients on genetic counseling attendance.

Authors:  Adam H Buchanan; Carol A Christianson; Tiffany Himmel; Karen P Powell; Astrid Agbaje; Geoffrey S Ginsburg; Vincent C Henrich; Lori A Orlando
Journal:  J Genet Couns       Date:  2014-08-15       Impact factor: 2.537

3.  Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

Authors:  Bronson D Riley; Julie O Culver; Cécile Skrzynia; Leigha A Senter; June A Peters; Josephine W Costalas; Faith Callif-Daley; Sherry C Grumet; Katherine S Hunt; Rebecca S Nagy; Wendy C McKinnon; Nancie M Petrucelli; Robin L Bennett; Angela M Trepanier
Journal:  J Genet Couns       Date:  2011-12-02       Impact factor: 2.537

4.  Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Authors:  L Wideroff; S T Vadaparampil; M H Greene; S Taplin; L Olson; A N Freedman
Journal:  J Med Genet       Date:  2005-03-22       Impact factor: 6.318

5.  Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-02-18       Impact factor: 25.391

6.  Interviews with primary care physicians regarding taking and interpreting the cancer family history.

Authors:  Marie E Wood; Alan Stockdale; Brian S Flynn
Journal:  Fam Pract       Date:  2008-09-01       Impact factor: 2.267

7.  Validation of My Family Health Portrait for six common heritable conditions.

Authors:  Flavia M Facio; W Gregory Feero; Amy Linn; Neal Oden; Kandamurugu Manickam; Leslie G Biesecker
Journal:  Genet Med       Date:  2010-06       Impact factor: 8.822

8.  Family history-taking in community family practice: implications for genetic screening.

Authors:  L S Acheson; G L Wiesner; S J Zyzanski; M A Goodwin; K C Stange
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822

9.  Most patients with colorectal tumors at young age do not visit a cancer genetics clinic.

Authors:  Lucia I H Overbeek; Nicoline Hoogerbrugge; Joannes H J M van Krieken; Fokko M Nagengast; Theo J M Ruers; Marjolijn J L Ligtenberg; Rosella P M G Hermens
Journal:  Dis Colon Rectum       Date:  2008-08       Impact factor: 4.585

10.  Developing Family Healthware, a family history screening tool to prevent common chronic diseases.

Authors:  Paula W Yoon; Maren T Scheuner; Cynthia Jorgensen; Muin J Khoury
Journal:  Prev Chronic Dis       Date:  2008-12-15       Impact factor: 2.830

View more
  8 in total

Review 1.  What characterizes cancer family history collection tools? A critical literature review.

Authors:  J E Cleophat; H Nabi; S Pelletier; K Bouchard; M Dorval
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

2.  Utilization of clinical genetic counseling among childhood and young adult cancer survivors in a registry trial.

Authors:  Nassim Anderson; Arash Delavar; Danielle Novetsky Friedman; Vijai Joseph; Nidha Mubdi; Kevin C Oeffinger; Charles A Sklar; Kenneth Offit; Matthew Matasar; Nirupa Raghunathan; Zoltan Antal; David Straus; Michael Walsh; Alicia Latham; Emily S Tonorezos
Journal:  J Community Genet       Date:  2020-07-16

3.  Perceptions and care Recommendations from Previvors: Qualitative analysis of female BRCA1/2 mutation Carriers' experience with genetic testing and counseling.

Authors:  Kate E Dibble; Laura K M Donorfio; Preston A Britner; Keith M Bellizzi
Journal:  Gynecol Oncol Rep       Date:  2022-05-02

4.  What do cancer patients' relatives think about addressing cancer family history and performing genetic testing in palliative care?

Authors:  Jude E Cléophat; Ana Marin; Sylvie Pelletier; Yann Joly; Pierre Gagnon; Alberte Déry; Jocelyne Chiquette; Bruno Gagnon; Louis Roy; Vasiliki Bitzas; Hermann Nabi; Michel Dorval
Journal:  Eur J Hum Genet       Date:  2019-09-16       Impact factor: 4.246

Review 5.  Initiatives to Scale Up and Expand Reach of Cancer Genomic Services Outside of Specialty Clinical Settings: A Systematic Review.

Authors:  Yue Guan; Colleen M McBride; Hannah Rogers; Jingsong Zhao; Caitlin G Allen; Cam Escoffery
Journal:  Am J Prev Med       Date:  2020-11-07       Impact factor: 5.043

6.  Feasibility of Utilizing PREMM Score for Lynch Syndrome Identification in an Urban, Minority Patient Population.

Authors:  Brigid Adviento; Michael Conner; Alexander Sarkisian; Nicolette Walano; Hans Andersson; Jordan Karlitz
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

Review 7.  Family history tools for primary care: A systematic review.

Authors:  Špela Miroševič; Zalika Klemenc-Ketiš; Borut Peterlin
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

8.  A qualitative study of barriers to genetic counseling and potential for mobile technology education among women with ovarian cancer.

Authors:  Rachel Isaksson Vogel; Kristin Niendorf; Heewon Lee; Sue Petzel; Hee Yun Lee; Melissa A Geller
Journal:  Hered Cancer Clin Pract       Date:  2018-07-04       Impact factor: 2.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.